SCHEMBL22928221

SCHEMBL22928221

O=S12(c3ccccc3-c3ccccc31)c1ccccc1-c1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ CDC25B P30305 3/20 0.40
▸ MAOA P21397 3/20 0.38
▸ POLB P06746 3/20 0.38
▸ S100A4 P26447 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ APAF1 O14727 2/20 0.38
▸ TDP2 O95551 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CES1 P23141 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ BLM P54132 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CES2 O00748 1/20 0.38
▸ TERT O14746 1/20 0.38
▸ NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928353 0.73 KCNA3 (0.32) MAPK1LMNAMAPTALDH1A1L3MBTL1
SCHEMBL22928210 0.72 KDM4E (0.44) POLBKDM4EALDH1A1L3MBTL1GPR3
SCHEMBL29437946 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL58152 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL29067593 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL28694051 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL4368339 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL49870 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL11875421 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB
SCHEMBL29543474 0.62 MEN1 (0.61) MEN1KMT2ACDC25BMAOAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS C1S, DRD1, DRD3 MEN1 906/4885KMT2A 3950/4885CDC25B 722/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 MEN1 906/4885KMT2A 3950/4885CDC25B 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback